Glomerular disorder characterized by massive proteinuria (>3.5 g/24 hours in adults or >40 mg/m²/hour in children), leading to hypoalbuminemia, generalized edema, hyperlipidemia, and lipiduria
Aetiology
Primary (Idiopathic) Glomerular Diseases
- Minimal Change Disease (MCD)
- Most common cause in children
- Often associated with atopy, infection, or vaccination
- Focal Segmental Glomerulosclerosis (FSGS)
- Most common cause in adults
- Can be primary or secondary (HIV, obesity, sickle cell disease)
- Membranous Nephropathy
- Common in adults
- May be idiopathic (anti-PLA2R antibodies) or secondary
- Membranoproliferative GN (rarely nephrotic-predominant)
Secondary Causes
- Diabetes mellitus (diabetic nephropathy)
- Systemic lupus erythematosus
- Amyloidosis
- Infections (HIV, hepatitis B and C)
- Drugs (NSAIDs, gold)
- Malignancies (solid tumors, lymphoma)
Pathophysiology
- Podocyte injury → effacement of foot processes
- Loss of size and charge selectivity of GBM
- Massive leakage of plasma proteins, especially albumin
- Hypoalbuminemia → decreased plasma oncotic pressure
- Compensatory hepatic synthesis of lipoproteins → hyperlipidemia
- Sodium and water retention → generalized edema
Clinical presentation
Edema (Cardinal Feature)
- Generalized (anasarca)
- Periorbital edema (morning)
- Peripheral edema
- Ascites and pleural effusion in severe cases
Urinary Abnormalities
- Frothy or foamy urine
- Oliguria (in advanced disease)
- Lipiduria (fatty casts, oval fat bodies)
Systemic Manifestations
- Fatigue
- Weight gain
- Susceptibility to infections
- Thromboembolic events (renal vein thrombosis, DVT)
Type | Definition |
Steroid-sensitive | Urine protein nil/trace for 3 consecutive days |
Steroid-Resistant | No remission ≥4–6 weeks |
Steroid-Dependent | Two consecutive relapses during taper/≤14 days |
Frequently Relapsing | ≥2 relapses/6 mo or ≥4/yr |
Infrequently Relapsing | Less frequent relapses |
Investigations
Urinalysis
- Proteinuria >3.5 g/day
- Fatty casts
- Oval fat bodies (Maltese cross under polarized light)
Blood Tests
- Hypoalbuminemia
- Hyperlipidemia
- Possible azotemia in advanced disease
- Reduced immunoglobulins
Serologic and Etiologic Workup
- ANA, anti-dsDNA
- Hepatitis B and C serology
- HIV testing
- Anti-PLA2R antibodies (membranous nephropathy)
Renal Biopsy
- Indicated in most adults
- Often not required in children with suspected MCD
Management
- Salt restriction
- Fluid restriction (if significant edema)
- Corticosteroids
- Prednisone 2mg/kg/day
- Diuretics (loop ± thiazide)
- Furosemide 1-3mg/kg/day
- ACE inhibitors or ARBs to reduce proteinuria
- Statins for hyperlipidemia
- Anticoagulation (selected high-risk patients)
Disease | Specific Treatment |
Minimal Change Disease | Corticosteroids |
FSGS | Steroids ± calcineurin inhibitors |
Membranous nephropathy | Immunosuppression (risk stratified) |
Diabetic nephropathy | Glycemic and BP control |